| Literature DB >> 31817012 |
Noelia Lahoz-García1, Marta Milla-Tobarra1,2, Antonio García-Hermoso3,4, Monserrat Hernández-Luengo1,5, Diana P Pozuelo-Carrascosa1, Vicente Martínez-Vizcaíno1,6.
Abstract
Full-fat dairy has been traditionally associated with obesity and cardiovascular disease (CVD); however, recent evidence shows that the amount of dairy intake might have a beneficial effect over these pathologies, regardless of their fat content. The aim of this study was to examine the association between the intake of dairy products (including milk with different fat contents) with both adiposity and serum lipid concentration, adjusted by cardiorespiratory fitness (CRF), in Spanish schoolchildren. A cross-sectional study of 1088 children, aged 8 to 11 years, was conducted in which anthropometric variables (body mass index (BMI), waist circumference (WC), fat mass percentage (FM%) and fat mass index (FMI)), blood lipid profile, and dairy intake (using a food frequency questionnaire), and CRF (through a 20-m shuttle run test) were measured. Results showed that children with lower BMI, WC, FM%, and FMI had higher whole-fat milk intake and lower skimmed and semi-skimmed milk intake than children with higher BMI, WC, FM%, and FMI. Children with normal levels of triglycerides and high density lipoproteins (HLD) cholesterol consumed more whole-fat milk and less reduced-fat milk than children with dyslipidemic patterns. These relationships persisted after adjustment for CRF. Our findings suggest that full-fat milk intake should be promoted in children without obesity or high cardiometabolic risk.Entities:
Keywords: cardiorespiratory fitness; dairy intake; food frequency questionnaire; lipid profile; obesity; schoolchildren
Mesh:
Year: 2019 PMID: 31817012 PMCID: PMC6950103 DOI: 10.3390/nu11122940
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Characteristics of the study sample by sex.
| Total ( | Boys ( | Girls ( | |
|---|---|---|---|
| Age | 9.5 ± 0.7 | 9.5 ± 0.7 | 9.5 ± 0.7 |
| Weight, kg | 37.4 ± 9.2 | 37.7 ± 9.6 | 37.0 ± 8.8 |
| Height, m | 139.6 ± 7.0 | 139.8 ± 7.3 | 139.4 ± 6.8 |
| BMI, kg/m2 | 19.0 ± 3.7 | 19.2 ± 3.8 | 18.8 ± 3.5 |
| Normal weight 1 | 702 (64.5) | 342 (62.4) | 360 (66.7) |
| Overweight | 277 (25.5) | 148 (27.0) | 129 (23.8) |
| Obese | 109 (10.0) | 58 (10.6) | 51 (9.5) |
| Waist circumference, cm | 67.6 ± 9.4 | 68.2 ± 9.7 * | 67.0 ± 9.0 * |
| FM% | 25.4 ± 6.8 | 23.9 ± 7.1 ** | 26.8 ± 6.1 ** |
| FMI (kg/m2) | 5.0 ± 2.3 | 4.8 ± 2.5 * | 5.2 ± 2.2 * |
| Triglycerides, mg/dL | 68.7 ± 34.4 | 65.2 ± 34.8 ** | 72.2 ± 36.2 ** |
| Total cholesterol, mg/dL | 169.0 ± 27.6 | 169.3 ± 27.0 | 168.8 ± 28.1 |
| HDL cholesterol, mg/dL | 59.6 ± 13.3 | 61.1 ± 13.8 ** | 58.1 ± 12.6 ** |
| LDL cholesterol, mg/dL | 97.2 ± 23.3 | 96.6 ± 22.7 | 97.8 ± 23.8 |
| CRF Stage, | 3.5 ± 1.7 | 4.1 ± 1.8 ** | 2.9 ± 1.3 ** |
| Weekly consumption | |||
| Whole fat milk | 3.5 ± 3.4 | 3.5 ± 3.4 | 3.4 ± 3.4 |
| (Semi-) skimmed milk | 3.7 ± 3.4 | 3.7 ± 3.4 | 3.8 ± 3.4 |
| Cheese | 2.8 ± 2.3 | 2.8 ± 2.3 | 2.8 ± 2.4 |
| Other milk products | 4.6 ± 2.4 | 4.8 ± 2.4 * | 4.4 ± 2.5 * |
| Total dairy products | 12.8 ± 5.9 | 12.7 ± 6.1 | 12.9 ± 5.7 |
BMI: body mass index; FM%: fat mass percentage; FMI: fat mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; CRF: cardiorespiratory fitness; 1 Gender- and age-specific BMI cut off defined by Cole et al. [25]. Data are presented as mean ± S.D and number and proportions (%) for categorical data. Gender group comparisons were conducted by Student’s t-test for continuous variables and Pearson’s χ2 for categorical variables. * p < 0.05; ** p < 0.001.
Correlation coefficients between food group consumption with cardiometabolic risk variables and cardiorespiratory fitness.
| Variables | Whole Fat Milk | (Semi-) Skimmed Milk | Cheese | Other Milk Products | Total Dairy Products |
|---|---|---|---|---|---|
| BMI | −0.238 ** | 0.216 ** | 0.047 | −0.045 | −0.046 |
| WC | −0.205 ** | 0.181 ** | 0.074 * | −0.017 | −0.033 |
| FM% | −0.213 ** | 0.189 ** | 0.045 | −0.072 * | −0.012 |
| FMI | −0.238 ** | 0.210 ** | 0.041 | −0.061 * | −0.034 |
| Triglycerides | −0.108 ** | 0.106 ** | 0.042 | −0.047 | −0.051 |
| Total cholesterol | −0.058 | −0.001 | 0.081 * | −0.022 | 0.024 |
| HDL cholesterol | 0.085 ** | −0.128 ** | 0.028 | 0.050 | 0.069 * |
| LDL cholesterol | −0.090 ** | 0.048 | 0.065 * | −0.042 | −0.007 |
| CRF | 0.124 ** | −0.089 ** | −0.045 | 0.065 * | −0.002 |
BMI: body mass index; WC: waist circumference; FM%: fat mass percentage; FMI: fat mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; CRF: cardiorespiratory fitness. * p < 0.05; ** p < 0.001.
Differences in weekly dairy consumption by adiposity categories.
| Model 1 | Model 2 | ||||||||||
| Whole fat milk | (Semi-) skimmed milk | Cheese | Other milk products | Total dairy products | Whole fat milk | (Semi-) skimmed milk | Cheese | Other milk products | Total dairy products | ||
| BMI 1 | Normal weight ( | 4.0 ± 0.1 a,b | 3.3 ± 0.1 a,b | 2.8 ± 0.1 | 4.7 ± 0.1 | 13.0 ± 0.2 | 4.0 ± 0.1 a,b | 3.4 ± 0.1 a,b | 2.8 ± 0.1 | 4.7 ± 0.1 | 13.0 ± 0.2 |
| Overweight ( | 2.9 ± 0.2 c | 4.1 ± 0.2 c | 2.9 ± 0.1 | 4.6 ± 0.1 | 12.8 ± 0.3 | 2.9 ± 0.2 c | 4.2 ± 0.2 c | 2.8 ± 0.2 | 4.7 ± 0.2 | 12.8 ± 0.4 | |
| Obese ( | 1.4 ± 0.4 | 5.5 ± 0.3 | 3.0 ± 0.2 | 4.4 ± 0.2 | 11.6 ± 0.5 | 1.5 ± 0.4 | 5.5 ± 0.4 | 2.9 ± 0.3 | 4.4 ± 0.3 | 11.6 ± 0.6 | |
|
|
|
| 0.770 | 0.491 | 0.075 |
|
| 0.938 | 0.665 | 0.114 | |
| WC | Low ( | 4.0 ± 0.2 e | 3.2 ± 0.2 e | 2.4 ± 0.1 d,e | 4.7 ± 0.1 | 12.8 ± 0.3 | 3.9 ± 0.2 e | 3.4 ± 0.2 e | 2.4 ± 0.2 d | 4.6 ± 0.2 | 12.7 ± 0.4 |
| Medium ( | 3.7 ± 0.2 f | 3.6 ± 0.2 f | 3.0 ± 0.1 | 4.6 ± 0.1 | 12.9 ± 0.2 | 3.7 ± 0.2 f | 3.6 ± 0.2 f | 3.0 ± 0.1 | 4.6 ± 0.1 | 12.9 ± 0.3 | |
| High ( | 2.3 ± 0.2 | 4.7 ± 0.2 | 3.0 ± 0.1 | 4.6 ± 0.2 | 12.6 ± 0.3 | 2.4 ± 0.2 | 4.7 ± 0.2 | 3.0 ± 0.2 | 4.7 ± 0.2 | 12.8 ± 0.4 | |
|
|
|
|
| 0.906 | 0.850 |
|
|
| 0.914 | 0.862 | |
| FM% | Low ( | 4.2 ± 0.2 e | 3.0 ± 0.2 e | 2.5 ± 0.2 | 4.8 ± 0.2 | 12.5 ± 0.4 | 4.2 ± 0.2 e | 3.1 ± 0.2 e | 2.5 ± 0.2 | 4.8 ± 0.2 | 12.4 ± 0.4 |
| Medium ( | 3.7 ± 0.2 f | 3.6 ± 0.1 f | 2.9 ± 0.1 | 4.7 ± 0.1 | 13.1 ± 0.2 | 3.7 ± 0.2 f | 3.7 ± 0.2 f | 2.9 ± 0.1 | 4.7 ± 0.1 | 13.2 ± 0.3 | |
| High ( | 2.3 ± 0.2 | 4.7 ± 0.2 | 2.9 ± 0.1 | 4.4 ± 0.2 | 12.4 ± 0.3 | 2.3 ± 0.2 | 4.8 ± 0.2 | 2.9 ± 0.2 | 4.3 ± 0.2 | 12.4 ± 0.4 | |
|
|
|
| 0.079 | 0.130 | 0.130 |
|
| 0.145 | 0.138 | 0.072 | |
| FMI | Low ( | 4.1 ± 0.2 e | 3.1 ± 0.2 e | 2.6 ± 0.1 | 4.8 ± 0.2 | 12.6 ± 0.3 | 4.0 ± 0.2 e | 3.1 ± 0.2 e | 2.5 ± 0.2 | 4.9 ± 0.2 | 12.5 ± 0.4 |
| Medium ( | 3.7 ± 0.1 f | 3.6 ± 0.1 f | 2.9 ± 0.1 | 4.6 ± 0.1 | 13.0 ± 0.2 | 3.7 ± 0.2 f | 3.6 ± 0.2 f | 2.9 ± 0.1 | 4.6 ± 0.1 | 13.1 ± 0.3 | |
| High ( | 2.3 ± 0.2 | 4.7 ± 0.2 | 2.9 ± 0.1 | 4.4 ± 0.2 | 12.5 ± 0.3 | 2.4 ± 0.2 | 4.9 ± 0.2 | 2.9 ± 0.2 | 4.4 ± 0.2 | 12.6 ± 0.4 | |
|
|
|
| 0.081 | 0.191 | 0.360 |
|
| 0.167 | 0.214 | 0.246 | |
Data are presented as marginal estimated mean ± S.E. ANCOVA model 1: controlling for age and sex. Model 2 further adjustments for cardiorespiratory fitness. Abbreviations: BMI: body mass index; WC: waist circumference; FM%: fat mass percentage; FMI: fat mass index. 1 Gender- and age-specific BMI cut off defined by Cole et al. [25]. a Significant difference between normal weight and overweight; b Significant difference between normal weight and obese; c Significant difference between overweight and obese. d Significant difference between low and medium; e Significant difference between low and high; f Significant difference between medium and high. All the pairwise mean comparisons using Bonferroni post hoc test were statistically significant as shown in boldface type (p < 0.05).
Differences in weekly dairy consumption by serum lipid concentration risk category.
| Model 1 | Model 2 | ||||||||||
| Whole fat milk | (Semi-) skimmed milk | Cheese | Other milk products | Total dairy products | Whole fat milk | (Semi-) skimmed milk | Cheese | Other milk products | Total dairy products | ||
| Triglycerides | Normal ( | 3.5 ± 0.1 | 3.7 ± 0.1 | 2.8 ± 0.1 | 4.6 ± 0.1 | 12.9 ± 0.2 | 3.5 ± 0.1 | 3.7 ± 0.1 | 2.8 ± 0.1 | 4.6 ± 0.1 | 12.9 ± 0.2 |
| High ( | 2.8 ± 0.4 | 4.7 ± 0.3 | 3.2 ± 0.2 | 4.5 ± 0.2 | 12.7 ± 0.6 | 2.9 ± 0.4 | 4.6 ± 0.4 | 3.1 ± 0.2 | 4.6 ± 0.2 | 12.7 ± 0.6 | |
|
|
|
| 0.177 | 0.678 | 0.708 | 0.134 |
| 0.286 | 0.786 | 0.773 | |
| Total cholesterol | Normal ( | 3.5 ± 0.1 | 3.8 ± 0.1 | 2.8 ± 0.1 | 4.7 ± 0.1 | 12.9 ± 0.2 | 3.5 ± 0.1 | 3.8 ± 0.1 | 2.4 ± 0.2 | 4.7 ± 0.1 | 12.9 ± 0.2 |
| High ( | 3.1 ± 0.3 | 3.8 ± 0.3 | 2.9 ± 0.2 | 4.6 ± 0.2 | 12.8 ± 0.5 | 3.2 ± 0.2 | 3.8 ± 0.3 | 3.2 ± 0.2 | 4.6 ± 0.2 | 12.9 ± 0.5 | |
|
| 0.192 | 0.853 | 0.624 | 0.669 | 0.925 | 0.312 | 0.924 | 0.803 | 0.600 | 0.873 | |
| HDL cholesterol | Normal ( | 3.5 ± 0.1 | 3.7 ± 0.1 | 2.8 ± 0.1 | 4.6 ± 0.2 | 12.9 ± 0.2 | 3.5 ± 0.1 | 3.7 ± 0.1 | 2.8 ± 0.1 | 4.6 ± 0.1 | 12.9 ± 0.2 |
| Low ( | 2.0 ± 0.5 | 5.4 ± 0.5 | 3.1 ± 0.4 | 4.7 ± 0.2 | 12.7 ± 0.8 | 2.0 ± 0.5 | 5.5 ± 0.5 | 3.1 ± 0.4 | 4.8 ± 0.4 | 13.2 ± 0.9 | |
|
|
|
| 0.529 | 0.879 | 0.876 |
|
| 0.432 | 0.579 | 0.705 | |
| LDL cholesterol | Normal ( | 3.5 ± 0.1 | 3.7 ± 0.1 | 2.9 ± 0.1 | 4.7 ± 0.1 | 12.9 ± 0.2 | 3.5 ± 0.1 | 3.8 ± 0.1 | 2.8 ± 0.1 | 4.7 ± 0.1 | 12.8 ± 0.2 |
| High ( | 3.2 ± 0.4 | 4.0 ± 0.4 | 2.9 ± 0.3 | 4.5 ± 0.3 | 12.8 ± 0.6 | 3.3 ± 0.4 | 4.0 ± 0.4 | 2.8 ± 0.3 | 4.4 ± 0.3 | 13.2 ± 0.6 | |
|
| 0.449 | 0.554 | 0.851 | 0.476 | 0.918 | 0. 696 | 0.617 | 0.926 | 0.423 | 0.631 | |
Data are presented as marginal estimated mean ± S.E. ANCOVA model 1: controlling for age and sex. Model 2: further adjustments for cardiorespiratory fitness. Abbreviations: HDL: high density lipoprotein; LDL: low density lipoprotein. Adverse serum lipid concentrations were defined as follows: triglycerides concentrations ≥ 100 mg/dL for children under ten years and ≥ 130 mg/dL for children over ten; total cholesterol concentrations ≥ 200 mg/dL; HDL cholesterol concentrations < 40 mg/dL and LDL cholesterol ≥ 130 mg/dL [26]. All the pairwise mean comparisons using Bonferroni post hoc test were statistically significant as shown in boldface type (p < 0.05).